Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes.

Auteurs Demozay D, Mas JC, Rocchi S, Van Obberghen E

Diabetes Jan 2008

The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain.

Auteurs Maurois P, Rocchi S, Pages N, Bac P, Stables JP, Gressens P, Vamecq J

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Déc 2007

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.

Auteurs Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG

Journal of immunology (Baltimore, Md. : 1950) Jun 2007

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.

Auteurs Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG

Journal of immunology (Baltimore, Md. : 1950) Jun 2007

Toll-like receptors and atopy.

Auteurs Fiset PO, Tulic MK, Hamid Q

The Journal of allergy and clinical immunology Aug 2005

Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production.

Auteurs Hajoui O, Janani R, Tulic M, Joubert P, Ronis T, Hamid Q, Zheng H, Mazer BD

The Journal of allergy and clinical immunology Sep 2004

Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model.

Auteurs Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA

The Laryngoscope May 2004

Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model.

Auteurs Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA

The Laryngoscope May 2004

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

Auteurs Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q

The Journal of allergy and clinical immunology Feb 2004

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

Auteurs Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q

The Journal of allergy and clinical immunology Feb 2004